NuvoAir, a leading digital healthcare company, has raised $11 million led by Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures.
Additional participation from a new strategic investor and existing investors brings the total Series A round to $25 million.
NuvoAir will be using the proceeds of this financing to expand its platform and team, accelerate the launch of its clinical services with risk-bearing providers and Health Plans, and launch new clinical trial partnerships globally.
